News

Veristat Congratulates TESARO on the FDA Approval of ZEJULA™

May 30, 2017

SOUTHBOROUGH, MA –  May 30, 2017 –   Veristat, a full service Clinical Research Organization (CRO), congratulates TESARO, Inc. on the approval of ZEJULA™.  

Read More

Veristat Acknowledged on Boston Business Journal’s “Fast 50” List for a Second Consecutive Year

May 15, 2017

Ranked as one of the Top 50 Fastest Growing Private Companies in Massachusetts

Read More

Veristat Appoints James Roach, MD as Chief Medical Officer

November 7, 2016

Veristat Strengthens its Clinical Operations, Medical and Regulatory Affairs Offerings


SOUTHBOROUGH, MA – November 07, 2016 – Veristat announced that it has appointed James (Jim) Roach, MD, FACP, FCCP as its new Chief Medical Officer to bolster the expansion of its clinical operations, medical and regulatory affairs offerings.
Read More

Veristat Formalizes its Strategic Decision Consulting Services

November 1, 2016

SOUTHBOROUGH, MA –  November 01, 2016Veristat, a full service consultative Clinical Research Organization (CRO), announced today the formal launch of its Strategic Decision Consulting service offering to help pharmaceutical, biotechnology and medical device firms solve the unique and complex challenges they face throughout the development process.  

Read More